DekaBank Deutsche Girozentrale’s Karyopharm Therapeutics KPTI Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,413	Closed	-$211K	–	1448
2021 Q3	$211K	Hold	2,413	–	–	﹤0.01%	1201
2021 Q2	$364K	Hold	2,413	–	–	﹤0.01%	1122
2021 Q1	$355K	Hold	2,413	–	–	﹤0.01%	1080
2020 Q4	$547K	Hold	2,413	–	–	﹤0.01%	1003
2020 Q3	$515K	Buy	+2,413	New	+$590K	﹤0.01%	927
2019 Q4	–	Sell	-1,093	Closed	-$161K	–	1178
2019 Q3	$161K	Sell	1,093 -1,094	-50%	-$148K	﹤0.01%	878
2019 Q2	$201K	Buy	2,187 +867	+66%	+$69.6K	﹤0.01%	1013
2019 Q1	$419K	Buy	1,320 +227	+21%	+$25.2K	﹤0.01%	937
2018 Q4	$152K	Sell	1,093 -227	-17%	-$38.3K	﹤0.01%	1006
2018 Q3	$419K	Sell	1,320 -33	-2%	-$9.12K	﹤0.01%	959
2018 Q2	$344K	Hold	1,353	–	–	﹤0.01%	980
2018 Q1	$269K	Buy	+1,353	New	+$270K	﹤0.01%	955
2016 Q2	–	Sell	-1,033	Closed	-$134K	–	1022
2016 Q1	$134K	Sell	1,033 -180	-15%	-$19.9K	﹤0.01%	908
2015 Q4	$243K	Buy	1,213 +13	+1%	+$2.81K	﹤0.01%	829
2015 Q3	$190K	Buy	1,200 +47	+4%	+$12.6K	﹤0.01%	882
2015 Q2	$471K	Buy	1,153 +40	+4%	+$17.3K	0.01%	713
2015 Q1	$511K	Buy	+1,113	New	+$480K	0.01%	707

Other funds holding KPTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

DekaBank Deutsche Girozentrale's KPTI Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Karyopharm Therapeutics (KPTI) in Q4 2021, closing a stake of 2,413 shares — an estimated $211K sold.

DekaBank Deutsche Girozentrale first reported a position in KPTI in Q1 2015 and held it in 17 quarters. The position peaked at $547K in Q4 2020. 143 funds tracked by Wall St. Rank hold KPTI as of Q4 2021.

DekaBank Deutsche Girozentrale reported no remaining Karyopharm Therapeutics position as of Q4 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 2,413 Karyopharm Therapeutics shares in Q4 2021, an estimated $211K.
DekaBank Deutsche Girozentrale first reported a position in Karyopharm Therapeutics in Q1 2015 and held it in 17 quarters.
DekaBank Deutsche Girozentrale's Karyopharm Therapeutics position peaked at $547K in Q4 2020.
143 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.